Zai Lab Stock Fundamentals
| ZLAB Stock | USD 17.64 0.69 3.76% |
As of the 27th of January, Zai Lab maintains the Mean Deviation of 1.89, standard deviation of 2.52, and Market Risk Adjusted Performance of (6.14). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zai Lab, as well as the relationship between them.
Zai Lab Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.4637 | Revenue |
Zai | Select Account or Indicator | Build AI portfolio with Zai Stock |
Zai Lab Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zai Lab Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zai Lab Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zai Lab Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zai Fundamental Market Drivers
Zai Upcoming Events
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Zai Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Zai Lab is extremely important. It helps to project a fair market value of Zai Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Zai Lab's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zai Lab's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zai Lab's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.90) | Revenue Per Share | Quarterly Revenue Growth 0.135 | Return On Assets | Return On Equity |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zai Lab 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zai Lab's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zai Lab.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Zai Lab on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Zai Lab or generate 0.0% return on investment in Zai Lab over 90 days. Zai Lab is related to or competes with Legend Biotech, Disc Medicine, Ascentage Pharma, Scholar Rock, Ideaya Biosciences, Centessa Pharmaceuticals, and Xenon Pharmaceuticals. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and ... More
Zai Lab Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zai Lab's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zai Lab upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 10.32 | |||
| Value At Risk | (4.21) | |||
| Potential Upside | 4.56 |
Zai Lab Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zai Lab's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zai Lab's standard deviation. In reality, there are many statistical measures that can use Zai Lab historical prices to predict the future Zai Lab's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (6.15) |
Zai Lab January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (6.14) | |||
| Mean Deviation | 1.89 | |||
| Coefficient Of Variation | (389.48) | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.36 | |||
| Information Ratio | (0.29) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (6.15) | |||
| Maximum Drawdown | 10.32 | |||
| Value At Risk | (4.21) | |||
| Potential Upside | 4.56 | |||
| Skewness | 0.344 | |||
| Kurtosis | 0.742 |
Zai Lab Backtested Returns
Zai Lab shows Sharpe Ratio of -0.23, which attests that the company had a -0.23 % return per unit of risk over the last 3 months. Zai Lab exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zai Lab's Mean Deviation of 1.89, standard deviation of 2.52, and Market Risk Adjusted Performance of (6.14) to validate the risk estimate we provide. The firm maintains a market beta of 0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zai Lab's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zai Lab is expected to be smaller as well. At this point, Zai Lab has a negative expected return of -0.56%. Please make sure to check out Zai Lab's value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Zai Lab performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.65 |
Very good reverse predictability
Zai Lab has very good reverse predictability. Overlapping area represents the amount of predictability between Zai Lab time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zai Lab price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Zai Lab price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Zai Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Zai Lab has 110.59 M of shares currently outstending. This is 38.74% lower than that of the Biotechnology sector and 3.5% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 80.66% higher than that of the company.
Zai Lab Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zai Lab's current stock value. Our valuation model uses many indicators to compare Zai Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zai Lab competition to find correlations between indicators driving Zai Lab's intrinsic value. More Info.Zai Lab is rated fourth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At present, Zai Lab's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zai Lab's earnings, one of the primary drivers of an investment's value.Zai Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zai Lab's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zai Lab could also be used in its relative valuation, which is a method of valuing Zai Lab by comparing valuation metrics of similar companies.Zai Lab is currently under evaluation in shares outstanding category among its peers.
Zai Lab Current Valuation Drivers
We derive many important indicators used in calculating different scores of Zai Lab from analyzing Zai Lab's financial statements. These drivers represent accounts that assess Zai Lab's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Zai Lab's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 603.4M | 301.7M | 256.1M | 2.7B | 2.4B | 2.5B | |
| Enterprise Value | (345.2M) | (686.4M) | (518.9M) | 2.4B | 2.1B | 2.2B |
Zai Lab ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zai Lab's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zai Lab's managers, analysts, and investors.Environmental | Governance | Social |
Zai Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.47) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 1.53 B | ||||
| Shares Outstanding | 110.59 M | ||||
| Shares Owned By Insiders | 1.80 % | ||||
| Shares Owned By Institutions | 33.50 % | ||||
| Number Of Shares Shorted | 4.25 M | ||||
| Price To Book | 2.67 X | ||||
| Price To Sales | 4.60 X | ||||
| Revenue | 398.99 M | ||||
| Gross Profit | 40.55 M | ||||
| EBITDA | (234.57 M) | ||||
| Net Income | (257.1 M) | ||||
| Cash And Equivalents | 1.26 B | ||||
| Cash Per Share | 13.10 X | ||||
| Total Debt | 153.47 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 7.91 X | ||||
| Book Value Per Share | 6.87 X | ||||
| Cash Flow From Operations | (214.87 M) | ||||
| Short Ratio | 5.11 X | ||||
| Earnings Per Share | (1.90) X | ||||
| Price To Earnings To Growth | (0.17) X | ||||
| Target Price | 47.5 | ||||
| Number Of Employees | 1.87 K | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 2.03 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (2.45 B) | ||||
| Working Capital | 751.1 M | ||||
| Net Asset | 1.19 B |
About Zai Lab Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zai Lab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zai Lab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zai Lab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 28.3 M | 26.9 M | |
| Total Revenue | 458.8 M | 481.8 M | |
| Cost Of Revenue | 170 M | 178.5 M | |
| Stock Based Compensation To Revenue | 0.20 | 0.19 | |
| Sales General And Administrative To Revenue | 0.86 | 0.82 | |
| Research And Ddevelopement To Revenue | 0.68 | 0.64 | |
| Capex To Revenue | 0.18 | 0.17 | |
| Revenue Per Share | 0.36 | 0.34 | |
| Ebit Per Revenue | (0.64) | (0.67) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Check out Zai Lab Piotroski F Score and Zai Lab Altman Z Score analysis. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.90) | Revenue Per Share | Quarterly Revenue Growth 0.135 | Return On Assets | Return On Equity |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.